# A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

> **NCT07419867** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Chemotherapy plus dual-target therapy
- **DIAGNOSTIC_TEST:** Treatment including HER2 ADC
- **DIAGNOSTIC_TEST:** Treatment including immunotherapy
- **DIAGNOSTIC_TEST:** Treatment including Nectin-4 ADC
- **DIAGNOSTIC_TEST:** Treatment including Trop-2 ADC
- **DIAGNOSTIC_TEST:** Treatment including CDK4/6 inhibitor

## Key facts

- **NCT ID:** NCT07419867
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07419867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07419867, "A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07419867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*